ACCESS Newswire·Jun 24, 2026, 8:17 AM ET

Modular Medical Announces Commercial Availability of Pivot Tubeless Insulin Patch Pump Ahead of Commercial Expansion

Modular Medical announced the Pivot tubeless insulin patch pump is now commercially available in the U.S. following April 2026 FDA 510(k) clearance.
Pivot is the second fully electronic, tubeless insulin pump available in the United States, designed for adults on multiple daily injections.
The device features a removable two-part design, a 3 mL reservoir, an intuitive interface, & does not require battery recharging.
First shipments to patients began the week of the June 24, 2026 announcement, marking Modular Medical's transition to a commercial-stage company.
The company targets the "almost-pumper" population, representing approximately 70% of insulin-dependent adults still using injections.
Commercial expansion is expected to begin in Q4 2026, with an initial rollout to select high-volume endocrinology practices.
Full commercial launch is projected to expand across multiple metropolitan markets by late 2026.
Modular Medical was founded by Paul DiPerna, who previously founded Tandem Diabetes & invented the t:slim insulin pump.
The press release includes standard forward-looking statements regarding risks such as market acceptance, manufacturing volume, & regulatory conditions.